How many clinical trials are tracked of naltrexone?

61 trials are tracked, 6 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

naltrexone

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of naltrexone

61 trials tracked of naltrexone: 22 in phase 3 or 4 and 6 with published results. The most-cited published study has 260 citations.

61Trials tracked

22Phase 3 & 4

0Recruiting

6With published results

Phase distribution

Phase 4 12 Phase 3 10 Phase 2 34 Phase 1 2 Other / NA 3

Phase 4 Treatment for Alcoholism and Post-Traumatic Stress Disorder (Naltrexone) Completed · 260 cited
Phase 4 Pharmacogenetic Response to Naltrexone For Alcohol Dependence Completed · 117 cited
Phase 4 Managing Alcoholism in People Who Do Not Respond to Naltrexone Completed · 55 cited
Phase 4 Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia Completed · 27 cited
Phase 4 Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist Completed · 11 cited
Phase 3 Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL Completed · 8 cited

Show 44 more trials

Phase 4 An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder. Completed
Phase 4 Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS)) Completed
Phase 4 Endophenotype for Alcohol Misuse in Healthy Minority Populations Completed
Phase 4 Understanding Treatment Response With Naltrexone Among White Alcoholics Completed
Phase 4 Naltrexone for Heavy Drinking in Young Adults Completed
Phase 4 Naltrexone for Impulse Control Disorders in Parkinson's Disease Completed
Phase 4 Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability. Completed
Phase 3 Treatment Strategy for Alcohol Use Disorders in Veterans With TBI Completed
Phase 3 Clinical Trial to Reduce Drinking in Women With HIV Completed
Phase 3 Drug Treatment for Pathologic Gambling Disorder Completed
Phase 3 Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence Completed
Phase 3 Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention Completed
Phase 3 Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep Completed
Phase 3 Effects of Omegas 3 and 6 on Alcohol Dependence Completed
Phase 3 Naltrexone & SSRI in Alcoholics With Depression/PTSD Completed
Phase 3 Effectiveness of Gabapentin When Used With Naltrexone to Treat Alcohol Dependence Compared to Placebo and Naltrexone Alone Completed
Phase 2 Memantine and Naltrexone Treatment for Opioid Dependence Completed
Phase 2 Naltrexone in the Treatment of Trichotillomania Completed
Phase 2 Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence Completed
Phase 2 Naltrexone and Hypoglycemia in Type 1 Diabetes Completed
Phase 2 A Novel Human Lab Model for Screening AUD Medications Completed
Phase 2 Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects Completed
Phase 2 Naltrexone for Individuals of East Asian Descent Completed
Phase 2 The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse Completed
Phase 2 Medication Development in Alcoholism: Acamprosate Versus Naltrexone Completed
Phase 2 Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home Completed
Phase 2 Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM Completed
Phase 2 Medications for Stopping Cocaine Dependence and Preventing Relapse Completed
Phase 2 Effects of Naltrexone on Nicotine Reinforcement Completed
Phase 2 Naltrexone for At-Risk and Problem Drinking in Smoking Cessation Treatment Completed
Phase 2 An Open Label Trial of Bupropion and Naltrexone for Binge Drinking Completed
Phase 2 Optimizing Pharmacotherapy for Bipolar Alcoholics Completed
Phase 2 The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease Completed
Phase 2 Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain Completed
Phase 2 Sweet Preference and Alcohol Craving Completed
Phase 2 Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM) Completed
Phase 2 An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence Completed
Phase 2 Opioid Modulation and Neural Reward Activation in Healthy Adults Completed
Phase 2 Double-Blind Naltrexone in Kleptomania Completed
Phase 2 Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana Completed
Phase 2 Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate Completed
Phase 2 Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders Completed
Phase 2 Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers Completed
Phase 2 Low Dose Naltrexone for Chronic Pain From Arthritis Completed

Showing the 50 most-cited and recently-updated of 61 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.